#vivo

Collection of vivo news, found 26 news.

Angel Yeast's Breakthrough in Yeast Protein Research: AngeoPro Shown to Promote Calcium Absorption

 Angel Yeast (SH600298), a leading global food ingredients and biotechnology company, today announced a major ...

Private oil firms to import extra fuel supplies from Pertamina: Govt

Minister of Energy and Mineral Resources Bahlil Lahadalia announced an agreement with private gas station companies, ...

RI needs greater FOLU emission reductions to reach 2030 peak: Minister

Indonesia’s energy sector is unlikely to reach peak emissions by 2030, pushing the forestry and land use (FOLU) ...

Engine Biosciences and Experimental Drug Development Centre Partner to Advance Novel Therapies to Combat Cancer

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision ...

Celltrion’s monoclonal antibody treatment regdanvimab, approved by the European Commission for the treatment of COVID-19

Celltrion Group announced today that the European Commission (EC) has approved Regkirona (regdanvimab, CT-P59), one of ...

Celltrion receives CHMP positive opinion for regdanvimab (CT-P59) as one of the first monoclonal antibodies recommended as a treatment for COVID-19 by the CHMP

Celltrion Group announced today that the European Medicine’s Agency’s (EMA) Committee for Medicinal Products for ...

Vivo launches next generation all-metal smartphone X6

Vivo has officially announced the launch of its latest product, the Vivo X6, an all-metal body smartphone, at a press ...

Follow the World Cup Action from APAC on Twitter

The #WorldCup will happen on the pitch, but also on Twitter, giving people the chance to get closer to the action than ...

Polyplus-transfection Announces the Appointment of ten Additional Biologists and Chemists

-       - Polyplus-transfection celebrates 10 years of commercial growth and research and ...

Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Result

- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...

Polyplus-Transfection Raises EUR 2.5 Million in Latest Funding Round

-        - The Additional Funds Will Enable the Company to Expand its Therapeutic ...